Novo Nordisk's pricing procedures while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, pointing out the stark distinction involving U.S. costs and people in Europe and copyright.But Rybelsus and copyright do have some distinctions. As an example, Rybelsus arrives as an oral